Global X Genomics & Biotechnology ETF GNOM

Morningstar Medalist Rating

Morningstar’s Analysis GNOM

Will GNOM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Global X Genomics & Biotechnology ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GNOM

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings53.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

12.4814M
Healthcare

10x Genomics Inc Ordinary Shares - Class A

5.346M
Healthcare

Twist Bioscience Corp

5.326M
Healthcare

Guardant Health Inc

5.266M
Healthcare

Illumina Inc

4.936M
Healthcare

Natera Inc

4.775M
Healthcare

Qiagen NV

3.884M
Healthcare

Bio-Techne Corp

3.864M
Healthcare

Vertex Pharmaceuticals Inc

3.834M
Healthcare

Genscript Biotech Corp Class H

3.574M
Healthcare

Sponsor Center